Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Short term Debt: 2018-2025

Historic Short term Debt for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $445.0 million.

  • Dr Reddys Laboratories' Short term Debt rose 190.85% to $445.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $445.0 million, marking a year-over-year increase of 190.85%. This contributed to the annual value of $445.0 million for FY2025, which is 190.85% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Short term Debt stood at $445.0 million for FY2025, which was up 190.85% from $153.0 million recorded in FY2024.
  • In the past 5 years, Dr Reddys Laboratories' Short term Debt registered a high of $445.0 million during FY2025, and its lowest value of $90.0 million during FY2023.
  • For the 3-year period, Dr Reddys Laboratories' Short term Debt averaged around $229.3 million, with its median value being $153.0 million (2024).
  • Its Short term Debt has fluctuated over the past 5 years, first crashed by 74.79% in 2023, then soared by 190.85% in 2025.
  • Dr Reddys Laboratories' Short term Debt (MRY) stood at $316.0 million in 2021, then rose by 12.97% to $357.0 million in 2022, then crashed by 74.79% to $90.0 million in 2023, then soared by 70.00% to $153.0 million in 2024, then soared by 190.85% to $445.0 million in 2025.
  • Its Short term Debt stands at $445.0 million for FY2025, versus $153.0 million for FY2024 and $90.0 million for FY2023.